Steroid Induced Glaucoma Market Size & Share 2025-2035

Future Market Insights

Steroid Induced Glaucoma Market

Key Insight

The steroid induced glaucoma market is estimated to generate USD 1.2 billion in 2025 and is expected to reach USD 2.1 billion by 2035, reflecting a CAGR of 6.1%. By treatment, drug treatment is projected to account for 68.7% of the industry share in 2025. By steroid types, topical ocular steroids are expected to hold 70% of the industry share.

July 07, 2025

Anurag Sharma

250 Pages

Cite this Report

Steroid Induced Glaucoma Market

https://www.futuremarketinsights.com/reports/steroid-induced-glaucoma-market

License

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Bausch & Lomb Incorporated
Glaukos Corporation
Novartis
Ocular Therapeutix
Sun Pharmaceutical Industries Ltd
Thea Pharma Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Steroid Induced Glaucoma Market

Key Players

Similar Industry Reports